Core Viewpoint - The company has adjusted the repurchase price of the restricted stock incentive plan for 2022 to 4.7800 CNY per share due to the implementation of the 2024 annual profit distribution plan [1][4][5]. Summary by Sections Repurchase Price Adjustment - The repurchase price for the restricted stock was initially set at 4.9800 CNY per share and has been adjusted to 4.7800 CNY per share following the annual profit distribution [4][5]. - The adjustment is based on the cash dividend of 2.00 CNY per 10 shares distributed to shareholders, which amounts to a total cash dividend of 170,311,295.40 CNY [1][5]. Approval Process - The adjustment was approved during the 24th meeting of the 8th Board of Directors and the 24th Supervisory Board meeting held on July 16, 2025 [4][6]. - Prior approvals were obtained during the 20th meetings of the Board and Supervisory Board on April 24, 2025, and the annual shareholders' meeting on May 19, 2025 [2][3][4]. Impact on the Company - The adjustment of the repurchase price is not expected to have a significant impact on the company's financial status or operational results [5][6]. - The management team will continue to fulfill their responsibilities diligently to create value for shareholders [5]. Legal Compliance - The adjustment has been deemed legal and effective, complying with relevant laws and regulations regarding stock incentive plans [6].
众生药业: 关于调整2022年限制性股票激励计划回购价格的的公告